Why Cancer Outcomes Could Depend on AI Care Coordination
Published by: Medical Economics
Date: October 13, 2021
The healthcare industry is just beginning to uncover the impact of delayed cancer screenings and care on oncology outcomes. It’s a challenge that accelerated the use of artificial intelligence (AI) worldwide in monitoring cancer progression or recurrence—and it demonstrates AI’s strong potential for ensuring patients receive the right treatment at the right time.
See how Preveta can support your practice
Learn how Preveta can operationalize your care pathways
and help facilitate CCM reimbursement